Search for: "E.I. duPont de Nemours and Company"
Results 101 - 115
of 115
Sorted by Relevance
|
Sort by Date
16 Jan 2017, 5:44 pm
Shell Oil Company, et al., No. 16-713 BPCIA – Notice of Commercial Marketing: Apotex Inc., et al. v. [read post]
28 Sep 2016, 8:39 am
DuPont de Nemours & Company, No. 15-1499 (is proof of a “reasonable expectation of success” necessary to combine references in an obviousness case against a claimed combination invention) Patent Attorney Malpractice: Encyclopaedia Britannica v. [read post]
14 Nov 2016, 9:16 am
King Drug Company of Florence, Inc., et al., No. 15-1055 (antitrust reverse payment – appeal from the 3rd Cir.) 3. [read post]
13 Oct 2016, 6:50 am
DuPont de Nemours & Company, No. 15-1499 (is proof of a “reasonable expectation of success” necessary to combine references in an obviousness case against a claimed combination invention) Jurisdiction: GeoTag, Inc. v. [read post]
5 Jan 2020, 2:52 pm
Companies and their D&O insurers must now assume that the chance of any given U.S. [read post]
5 Jan 2020, 2:52 pm
Companies and their D&O insurers must now assume that the chance of any given U.S. [read post]
19 Nov 2009, 10:51 am
You've got a court in California, but nobody else, allowing "misrepresentation" liability for a brand-name company in a generic drug case. [read post]
29 May 2016, 9:38 am
Showing that Johns Manville was well aware of the extraordinarily great hazard of crocidolite would have been relatively easy to do from past transcripts, articles, speeches, and litigation conduct of the Johns Manville companies. [read post]
29 Mar 2021, 7:10 pm
Some notes on vexing issue, which fortunately has never serious issue for me. [read post]
19 Jul 2007, 1:47 pm
Such a duty would require drug manufacturers to rely upon the representations made by competitor drug companies. [read post]
5 Jul 2013, 5:00 am
A.D. 2011).The issue of whether a company complied or did not comply with FDA requirements is relevant to many aspects of the products liability lawsuit. [read post]
1 Oct 2009, 2:14 am
The removing defendant, a diverse drug company (of course!) [read post]
5 Apr 2007, 6:02 pm
On July 31, 2006, a unanimous Federal Trade Commission (“Commission” or “FTC”) ruled that Rambus Inc. [read post]
21 Mar 2010, 12:19 pm
DuPont de Nemours and Company to review environmental safety procedures at its industrial plant in Belle, W. [read post]
26 May 2015, 7:42 am
SJS/TEN is somewhat analogous in our sandbox to mesothelioma in asbestos cases, since plaintiffs often work backwards from the diagnosis to look for some drug company to sue. [read post]
